There was a mistake in Figure 1 as published. In the PDF of the article, the revised version of the Figure was not included. However, it is correct on the webpage. The corrected Figure 1 appears below.
Figure 1
The original version of this article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
cancer-associated fibroblasts, interleukin-6, prostate cancer, therapeutic resistance, tumor microenvironment
Citation
Frontiers Production Office (2026) Correction: IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities. Front. Immunol. 17:1789441. doi: 10.3389/fimmu.2026.1789441
Received
16 January 2026
Accepted
16 January 2026
Published
22 January 2026
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
17 - 2026
Updates
Copyright
© 2026 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.